Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics.

Current opinion in psychiatry - 1 Sept 2012

Ferentinos Panagiotis, Dikeos Dimitris

Abstract excerpt

PURPOSE OF REVIEW: High comorbidity rates for various medical conditions have been documented in schizophrenia, being explained by factors either inherent to the disease or associated with antipsychotic treatment. The aim of this study is to review the genetic factors contributing to medical comorbidity in schizophrenia. RECENT FINDINGS: Based on clinical genetic studies in schizophrenia, comorbid impaired...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Comorbidity
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Schizophrenia

Source

Identifiers

PMID: 22842659
DOI: 10.1097/YCO.0b013e3283568537

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics.PMID 22842659Read ↗

Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.Semantic proximity Read ↗

Identifying modifiable comorbidities of schizophrenia by integrating electronic health records and polygenic riskSemantic proximity Read ↗

Genetics of Common Antipsychotic-Induced Adverse EffectsSemantic proximity Read ↗

Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity.Semantic proximity Read ↗

Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical ImplicationsSemantic proximity Read ↗

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read ↗

New findings in pharmacogenetics of schizophreniaSemantic proximity Read ↗

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?Semantic proximity Read ↗

Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study.Semantic proximity Read ↗

Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia.Semantic proximity Read ↗

Co‐shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndromeSemantic proximity Read ↗

Pharmacogenetics and schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.